Management of Subclinical Hypothyroidism

MOspace/Manakin Repository

Breadcrumbs Navigation

Management of Subclinical Hypothyroidism

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3954

[+] show full item record


Title: Management of Subclinical Hypothyroidism
Author: Ibay, Annamarie D.; Bascelli, Lynda M.; Nashelsky, Joan
Keywords: hormone replacement
cardiac dysfunction
thyroid-stimulating hormone (TSH)
Date: 2005-05
Publisher: Family Physicians Inquiries Network
Citation: American Family Physician, 71(9) 2005.
Abstract: Treatment of subclinical hypothyroidism with levothyroxine may be of most benefit to patients with symptoms suggestive of hypothyroidism and those patients with thyroid-stimulating hormone (TSH) levels higher than 10 μIU per mL (10 mIU per L) or positive anti-thyroid peroxidase (TPO) antibodies. Levothyroxine is recommended for pregnant patients. For asymptomatic patients with TSH levels between 4.5 and 10 μIU per mL (4.5 and 10 mIU per L), treatment may not be beneficial, but their thyroid function should be monitored at six- to 12-month intervals. [Strength of recommendation: C, based on expert opinion and systematic reviews with troublesome heterogeneity of disease-oriented evidence]
URI: http://hdl.handle.net/10355/3954

This item appears in the following Collection(s)

[+] show full item record